Image de couverture de livre

Structure-guided discovery of marine natural products as glucokinase activators for type 2 diabetes mellitus: A computational perspective.

Fuente: PubMed

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Krishnakumar, Heyram, Jayaraman, Manikandan, Prabhu, Dhamodharan, Jeyakanthan, Jeyaraman
Format:	Artículo científico
Langue:	en
Publié:	Journal of molecular graphics & modelling 2026
Sujets:	Glucokinase Diabetes Mellitus, Type 2 Humans Biological Products Molecular Docking Simulation Hypoglycemic Agents Drug Discovery Molecular Dynamics Simulation Enzyme Activators Aquatic Organisms Protein Binding Ligands Structure-Activity Relationship Enzyme Activation
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Computational insights into marine natural products as potential antidiabetic agents targeting the SIK2 protein kinase domain.
par: Heyram, K, et autres
Publié: (2024)

Structural and functional insights into glycosyltransferase from Nocardia asteroides NCTC11293 and structure-guided discovery of marine and phytochemical leads through pharmacokinetic screening and molecular dynamics studies.
par: Muthuvairam Subbulakshmi, Maharaja, et autres
Publié: (2026)

Binding Stability and Catalytic Mechanism of a Novel Chitin Deacetylase from and Preparation of Chitosan.
par: Liang, Bicheng, et autres
Publié: (2025)

Computational screening of natural plant and marine compounds as potential inhibitors of Mycobacterium tuberculosis dihydrodipicolinate synthase.
par: Meena, Swati, et autres
Publié: (2026)

Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities.
par: Wang, Zimin, et autres
Publié: (2025)

Molecular Docking and Dynamics Simulations Reveal the Antidiabetic Potential of a Novel Fucoxanthin Derivative from .
par: Sigera, Sachini, et autres
Publié: (2025)

Exploring phytochemicals and marine natural products as alternative therapeutic agents targeting phosphotransacetylase (PTA) in Mycobacterium tuberculosis: An underexplored drug target.
par: Subramaniyan, Sneha, et autres
Publié: (2025)

Computer-aided screening of marine fungal metabolites as potential inhibitors of new Delhi metallo-beta-lactamase-1.
par: Shabbir, Farhat, et autres
Publié: (2025)

Unveiling an indole derivative YM818 as a novel tyrosinase inhibitor with anti-melanogenic and anti-melanin transfer effects.
par: Yang, Chunyan, et autres
Publié: (2025)

Exploring Marine natural products as potential Quorum sensing inhibitors by targeting the PqsR in Pseudomonas aeruginosa: Virtual screening assisted structural dynamics study.
par: Jayaraman, Manikandan, et autres
Publié: (2025)

Exploring marine-derived bacterial compounds targeting the μ-opioid receptor agonists through metabolic profiling to molecular modeling.
par: Boudrahem, Daouia, et autres
Publié: (2025)

Discovery and molecular mechanism of a novel antihypertensive peptide from Chlamydomonas reinhardtii based on molecular docking, molecular dynamics simulation, in vitro, and in vivo analysis.
par: Suo, Qishan, et autres
Publié: (2026)

Computational Analysis of Excavatolide B-Human STING Interactions Implicates a Cys148-Adjacent Corridor with Within-Cavity Sub-Pose Diversity.
par: Chang, Tien-Lin, et autres
Publié: (2026)

A Novel Sesterterpenoid, Petrosaspongin and γ-Lactone Sesterterpenoids with Leishmanicidal Activity from Okinawan Marine Invertebrates.
par: Jomori, Takahiro, et autres
Publié: (2024)

From Multi-Species Screening to Targeted Investigation: Discovery of ACE Inhibitory Peptides in via Peptidomics, Virtual Screening, and Molecular Dynamics Simulations.
par: Zhang, Haorui, et autres
Publié: (2026)

Diverse and Bioactive Lactones from the Sri Lankan Mangrove-Derived Fungus sp. SCSIO41445.
par: Wijerathna, Parakkrama, et autres
Publié: (2026)

Molecular Evolution and Adaptation Strategies in Marine Ciliates: An Inspiration for Cold-Adapted Enzyme Engineering and Drug Binding Analysis.
par: Pucciarelli, Sandra, et autres
Publié: (2024)

Cytochrome P450 Mediated Cyclohexane Ring Formation in Forazoline Biosynthesis.
par: Chen, Xinru, et autres
Publié: (2025)

Optimized ebselen derivatives as novel potent Escherichia coli β-glucuronidase covalent allosteric inhibitors.
par: Ying, Ti-Ti, et autres
Publié: (2025)

In Vitro and In Silico Studies on the Anti-H1N1 Activity of Bioactive Compounds from Marine-Derived .
par: Chen, Yung-Husan, et autres
Publié: (2025)

The Antioxidant Effects of Trypsin-Hydrolysate Derived from Abalone Viscera and Fishery By-Products, and the Angiotensin-I Converting Enzyme (ACE) Inhibitory Activity of Its Purified Bioactive Peptides.
par: Heo, Jun-Ho, et autres
Publié: (2024)

Data-Independent Acquisition-Based Quantitative Proteomics, Nontargeted Metabolomics, and Protein-Ligand Interaction Reveal the Mechanism of Baicalin Inhibiting βhemolytic/cytolytic Activities of .
par: Li, Guihua, et autres
Publié: (2026)

Chrysogenones A-E: Malonyl-Modified Ergosterone Derivatives from Deep-Sea-Derived sp. MCCC 3A00121 as Inhibitors of Renal Fibroblast Activation.
par: Li, Zeqing, et autres
Publié: (2026)

Structural Characteristics of Milt Peptides and Their Anti-Fatigue Activity via AMPK/PGC-1αMediated Energy Metabolism Regulation in Exercised Mice.
par: Zhang, Jiangjiang, et autres
Publié: (2026)

Unveiling the potential of Hamigeran-B from marine sponges as a probable inhibitor of Nipah virus RDRP through molecular modelling and dynamics simulation studies.
par: Skariyachan, S, et autres
Publié: (2024)

Unlocking the potential of marine natural product fragments for rational anticancer drug design: a computational approach.
par: Gomez, Marineil C, et autres
Publié: (2026)

Effects of Octacosanol Isolated from Leaves on Inhibiting the Activity of Pancreatic Lipase.
par: Dong, Xiaoying, et autres
Publié: (2025)

Identification of Marine Compounds Inhibiting NF-κBInducing Kinase Through Molecular Docking and Molecular Dynamics Simulations.
par: Yasir, Muhammad, et autres
Publié: (2024)

Non-Steroidal FXR Agonistic Dimeric 2-Methyl-4-(1-glycerol)furan with Lipid-Lowering Activities from Marine-Derived sp. ZSN1.
par: Jiang, Yongjun, et autres
Publié: (2025)

Quantitative Structure-Activity Relationship and Molecular Modeling Studies on a Series of Hydroxypyrrolo[2,1-c][1,4]Benzodiazepine-5,11-dione Acting as Angiotensin Converting Enzyme I Inhibitors
par: Sanober, Ayesha, et autres
Publié: (2021)

Novel Sulfated Oligosaccharide DP9 from Marine Algae, : A Potent Galectin-3 Inhibitor for Pancreatic Cancer Therapy.
par: Liu, Pingting, et autres
Publié: (2025)

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.
par: Bourg, Stéphane, et autres
Publié: (2026)

Structural insights into flexible pyruvate binding in an (S)-selective ω-transaminase.
par: Wu, Danni, et autres
Publié: (2026)

Significant improvement of the thermostability and catalytic efficiency of β-glucosidase Bgl59 via cysteine engineering and rational design.
par: Li, Lanlan, et autres
Publié: (2026)

Evaluating the estrogen degradation potential of laccase and peroxidase from Bacillus ligniniphilus L1 through integrated computational and experimental approaches.
par: Nawaz, Muhammad Zohaib, et autres
Publié: (2024)

Decoding the multifunctional potential of ursolic acid: antioxidant, antiproliferative, molecular dynamics, and biodegradability evaluations of a mangrove-derived terpenoid.
par: Parthiban, Anaikutti, et autres
Publié: (2025)

Revelation of Brevi-inflammin, a novel anti-inflammatory metabolite from Brevibacterium casei VRK 1, as a potent COX-2 inhibitor.
par: Chandrasekaran, Vishnupriya, et autres
Publié: (2025)

A Cinderella story in antimicrobials: CDPDP's perfect fit for multiple-pathway bacterial inhibition.
par: Ul Hassan, Syed Shams, et autres
Publié: (2025)

Antifungal phenolic glucosides and related congeners from the cold-seep-derived Talaromyces trachyspermus CS-106.
par: Feng, Xing-Yan, et autres
Publié: (2026)

Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways.
par: Huang, Jing, et autres
Publié: (2025)